Thyroid Disorders With Acute Coronary SyndromeNCT07082712
Investigate Relationship Between Thyroid Disorders and Acute Coronary Syndrome.
An observational study of Thyroid Disorders With Acute Coronary Syndrome, run by Sohag University at 1 site in Egypt.
Trial summary
Study Of Thyroid Disorders In Patients With Acute Coronary Syndrome At Sohag University Hospitals. Read more about this study
- Who is it for?
- Ages 20 years and older
- Conditions the study is for
- Thyroid Disorders With Acute Coronary Syndrome
- What is being tested?
- Thyroid profile
- How many people
- 300 participants
- Where
- 1 siteEgypt
- Study dates
- 28 Jun 2025to 1 Nov 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- All sexes
- Adult, Older adult
Study population: Patients With Acute Coronary Syndrome
Who may be able to join
- patients more than 20 years old who were diagnosed with ACS.
- Exclusion Criteria: - Patients known hypothyroidism or hyperthyroidism on treatment. Patients presented by acute decompensated heart failure. Patients with advanced malignancies. Patients with acute pulmonary thromboembolism.
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site, 1 recruiting
- Recruiting
Faculty of medicine sohag University
Sohag
Asmaa AbuBakr "MohamedAl-Mobdy", 01100799603, asmaa_abubakr_post@med.sohag.edu.eg
Asmaa AbuBakr "MohamedAl-Mobdy ", 01100799603, asmaa_abubakr_post@med.sohag.edu.eg
About this study
Official title: Study Of Thyroid Disorders In Patients With Acute Coronary Syndrome At Sohag University Hospitals .
Study Of Thyroid Disorders In Patients With Acute Coronary Syndrome At Sohag University Hospitals.
Read the detailed description
Our aim of the study to investigate relationship between thyroid disorders and acute coronary syndrome .We will study 300 hospitalized patients with a diagnosis of ACS to determine the prevalence of thyroid disorders, and their relationship with other known coronary risk factors. All patients included in the study will be subjected to:
Detailed medical history Detailed clinical examination
Laboratory investigation:
Thyroid function Tests (TSH, FT3, FT4) will collect from all the patients within 24 h of their admission to the coronary care unit (CCU).
Serum lipogram. cardiac enzymes.
- Being tested
- Thyroid profile
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Thyroid profileOther
Thyroid profile in patients with acute coronary syndrome within 24 hour from admission
What is being measured
The primary outcome is the main question the study is designed to answer.
Detection of Thyroid disorders in patient with acute coronary syndrome
Detection of Thyroid profile Tsh(µIU/mL))normal rang(.4-5.5). FreeT4(ng/dL) FreeT3(pmol/L)
Measured: Baseline(6 months of start of research)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Jul 2025
- Study start28 Jun 2025
- Primary completion1 Sep 2025 (estimated)
- Study completion1 Nov 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Thyroid Disorders With Acute Coronary SyndromeStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Asmaa Abobakr, Sohag University
- Investigators
- Asmaa AbuBakr "MohamedAl-Mobdy", Study chair, Shoag University HospitalsAsmaa AbuBakr "MohamedAl-Mobdy ", Principal investigator, Tertiary hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07082712
- Sponsor's protocol ID
- Soh-Med--25-6-4MS
- Status last verified
- Jul 2025
- First submitted
- 4 Jul 2025
- Last updated
- 24 Jul 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Study Of Thyroid Disorders In Patients With Acute Coronary Syndrome At Sohag University Hospitals .
- ClinicalTrials.gov ID
- NCT07082712
- Acronym / sponsor ID
- Soh-Med--25-6-4MS
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 28 Jun 2025 (actual)
- Primary completion
- 1 Sep 2025 (estimated)
- Study completion
- 1 Nov 2025 (estimated)
- First posted
- 24 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Study Of Thyroid Disorders In Patients With Acute Coronary Syndrome At Sohag University Hospitals.
Detailed description
Our aim of the study to investigate relationship between thyroid disorders and acute coronary syndrome .We will study 300 hospitalized patients with a diagnosis of ACS to determine the prevalence of thyroid disorders, and their relationship with other known coronary risk factors. All patients included in the study will be subjected to:
Detailed medical history Detailed clinical examination
Laboratory investigation:
Thyroid function Tests (TSH, FT3, FT4) will collect from all the patients within 24 h of their admission to the coronary care unit (CCU).
Serum lipogram. cardiac enzymes.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 20 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Patients With Acute Coronary Syndrome
Key inclusion criteria (2 listed)
- patients more than 20 years old who were diagnosed with ACS.
- Exclusion Criteria: - Patients known hypothyroidism or hyperthyroidism on treatment. Patients presented by acute decompensated heart failure. Patients with advanced malignancies. Patients with acute pulmonary thromboembolism.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Thyroid profileThyroid profile in patients with acute coronary syndrome within 24 hour from admission | Other | – |
Primary outcome
Detection of Thyroid disorders in patient with acute coronary syndrome
Time frame: Baseline(6 months of start of research)
Detection of Thyroid profile Tsh(µIU/mL))normal rang(.4-5.5). FreeT4(ng/dL) FreeT3(pmol/L)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Jul 2025.
Related trials for Thyroid Disorders With Acute Coronary Syndrome
Not yet recruitingObservational study
Prevalence and Prognostic Effects of Thyroid Abnormalities in Patients With Acute Coronary Syndrome.
Thyroid Dysfunction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Asmaa AbuBakr "MohamedAl-Mobdy" study chair
Shoag University Hospitals
Asmaa AbuBakr "MohamedAl-Mobdy " principal investigator
Tertiary hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Thyroid Disorders With Acute Coronary Syndrome, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 24 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Asmaa AbuBakr "MohamedAl-Mobdy " (01100799603, asmaa_abubakr_post@med.Sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Detection of Thyroid disorders in patient with acute coronary syndrome (time frame: Baseline(6 months of start of research)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2025.